WuHan Hvsen Biotechnology: CITIC Construction Investment Securities Co., Ltd. sponsorship summary report on the initial public offering of shares of Wuhan Huisheng Biotechnology Co., Ltd. and its listing on the GEM
Huisheng Biotech: Announcement on the results of the resale of Huisheng Convertible Bonds
Huisheng Biotech: Third Prompt Announcement on the Resale of Huisheng Convertible Bonds
Huisheng Biotech: Second Prompt Announcement on the Resale of Huisheng Convertible Bonds
Huisheng Biotech: First Prompt Announcement on the Resale of Huisheng Convertible Bonds
Huisheng Biotech: Notice on holding the first meeting of bond holders in 2023
Huisheng Biotech: An indicative announcement on the conditions that Huisheng Convertible Bonds are expected to trigger a downward correction in the conversion price
Huisheng Biotech: Announcement on the 2022 interest payment of Huisheng Convertible Bonds
Huisheng Biotech: Announcement on a 10% change in the proportion of convertible corporate bonds held by bond holders
Huisheng Biotech: Announcement on a 10% change in the proportion of convertible corporate bonds held by bond holders
Huisheng Biotech: 2021 Annual Equity Distribution Implementation Notice
Huisheng Biotech: Announcement on the 2021 Profit Distribution Plan
Huisheng Biotech: Online Roadshow Announcement on GEM Issuance of Convertible Corporate Bonds to Unspecified Targets
Huisheng Biotech: 1. The applicant and sponsoring agency responded to comments
Huisheng Biotech: 3 Supplemental Legal Opinions (4)
Huisheng Biotech: Issuance of registration process feedback implementation letter
Huisheng Biotech: Responses from issuers and sponsors to the implementation letter of the listing committee's review opinions
Huisheng Biotech: Reminder Announcement on Response to the GEM Listing Committee's Review and Implementation Letter on the Application for Issuance of Convertible Corporate Bonds to Unspecified Targets
Huisheng Biotech: Announcement on the Application for Issuance of Convertible Corporate Bonds to Unspecified Targets Reviewed and Approved by the Shenzhen Stock Exchange GEM Listing Committee
Huisheng Biotech: Implementation letter on the review opinions of the listing committee of Wuhan Huisheng Biotechnology Co., Ltd.
No Data